May 2, 2019
RegMed Investors’ (RMi) pre-open: insight is about understanding perception
May 1, 2019
RegMed Investors’ (RMi) pre-open: first trading day of the month of May
April 30, 2019
RegMed Investors’ (RMi) pre-open: Pharma’s report, Merck (MRK), Ely Lilly (LLY) and Pfizer (PFE)
April 29, 2019
RegMed Investors’ (RMi) pre-open: inversion or transposition
April 26, 2019
RegMed Investors’ (RMi) pre-open: TGIF, a dud or a bounce as the week ends
April 25, 2019
RegMed Investors’ (RMi) pre-open: “free” climbing the wall of worry
April 24, 2019
RegMed Investors’ (RMi) pre-open: volatility bubbles and risk boils just below the surface
April 23, 2019
RegMed Investors’ (RMi) pre-open: the oversold need to inch their way up the wall of worry
April 22, 2019
RegMed Investors’ (RMi) pre-open: I’d be picking at these bottoms
April 18, 2019
RegMed Investors’ (RMi) pre-open: are the oversold cheap enough on the last trading day of the week
April 17, 2019
RegMed Investors’ (RMi) pre-open: yippie-yi-yo-kai-yay
April 16, 2019
RegMed Investors’ (RMi) pre-open: it’s time for a spin game of “pick-up-stocks”
April 15, 2019
RegMed Investors’ (RMi) pre-open: run sector run
April 12, 2019
RegMed Investors’ (RMi) pre-open: potential for pricing bounces
April 11, 2019
RegMed Investors’ (RMi) pre-open: let the sector run yet, keep your eyes on who bounces their share price
April 10, 2019
RegMed Investors’ (RMi) pre-open: the sector is caught in a “prevailing mood”
April 9, 2019
RegMed Investors’ (RMi) pre-open: where are we as the sector goes in this market?
April 8, 2019
RegMed Investors’ (RMi) pre-open: don’t get too comfortable, leaps of faith are just that
April 4, 2019
RegMed Investors’ (RMi) pre-open: I am still considering the transmutation of share pricing’s value
April 3, 2019
RegMed Investors’ (RMi) pre-open: be ready for a transmutation of share pricing
April 2, 2019
RegMed Investors’ (RMi) pre-open: after some good gains, there is always a slip and pain ensues
April 1, 2019
RegMed Investors’ (RMi) pre-open: a new month and start of Q2
March 29, 2019
RegMed Investors’ (RMi) pre-open: progress in alleviating the sector’s oversold conditions
March 28, 2019
RegMed Investors’ (RMi) pre-open: the sector’s musical chairs has one less chair
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.